Hedley Mary Lynne 4
4 · Centessa Pharmaceuticals plc · Filed Jun 24, 2025
Insider Transaction Report
Form 4
Hedley Mary Lynne
Director
Transactions
- Award
Share Option (right to buy)
2025-06-20+40,000→ 40,000 totalExercise: $12.43Exp: 2035-06-20→ Ordinary Shares (40,000 underlying)
Footnotes (2)
- [F1]The shares subject to such option will vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the Issuer's next annual meeting of shareholders, subject to continued service as a director through the applicable vesting date.
- [F2]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.